このエントリーをはてなブックマークに追加
ID 31826
JaLCDOI
FullText URL
Author
Fujikawa, Tatsuya
Yamamoto, Kazuhide ORCID Kaken ID publons
Abstract

Serum des-gamma-carboxy prothrombin (DCP) is commonly used to detect hepatocellular carcinoma (HCC). This review focuses on the clinical features of DCP-positive HCC and the molecular function of DCP in HCC. DCP-positive HCC demonstrates more aggressive clinicopathological features than DCP-negative HCC. Analysis of the biological effects of DCP revealed that DCP acts as a growth factor in both an autocrine and paracrine manner. DCP stimulates HCC cell proliferation through the Met-Janus kinase 1-signal transducer and activator of transcription 3 signaling pathway, whereas for vascular endothelial cells, it stimulates cell proliferation and migration through the kinase insert domain receptor-phospholipase C-gamma-mitogen-activated protein kinase signaling pathway.

Keywords
des-gamma-carboxy prothrombin
hepatocellular carcinoma
signaling pathway
cell proliferation
angiogenesis
Amo Type
Review
Publication Title
Acta Medica Okayama
Published Date
2009-12
Volume
volume63
Issue
issue6
Publisher
Okayama University Medical School
Start Page
299
End Page
304
ISSN
0386-300X
NCID
AA00508441
Content Type
Journal Article
language
English
File Version
publisher
Refereed
True
PubMed ID
Web of Science KeyUT